A rating of 97 puts Esperion Therapeutics Inc (ESPR) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Esperion Therapeutics Inc's score of 97 means it scores higher than 97% of stocks in the industry. Esperion Therapeutics Inc also received an overall rating of 80, putting it above 80% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 91 out of the 148 industries.
ESPR has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on ESPR!